PIK3CD and Alzheimer disease: Similarly, the inhibition of the PI3K p110δ isoform has been shown to positively affect key AD symptoms, such as plaque formation, neuroinflammation, and cognitive decline, further supporting the potential of targeting the PI3K pathway in the therapeutic intervention of AD [273].